Pharmaceutical formulations

US7947654B2 · kind B2 · utility

Assignee

• Ferring B.V. · NL

Inventors

• Anders Nilsson · Västerås, SE
• Hans Lindner · Leichlingen, DE
• Jørgen Wittendorff · Copenhagen, DK

Key dates

• Filing date: Jun 18, 2009
• Grant date: May 24, 2011
• Expiry date: Feb 9, 2030

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61K9/2095
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

Good bioavailability of desmopressin can be obtained by means of an orodispersible pharmaceutical dosage form. Preferred dosage forms comprise desmopressin and an open matrix network which is an inert water-soluble or water-dispersible carrier material. Desmopressin formulated in this way is useful for voiding postponement, or the treatment or prevention of incontinence, primary noctural enuresis (PNE), nocturia or central diabetes insipidus. Peptides other than desmopressin can also be formulated in this way.